Highlights | Birth defects manuscript writing retreat 17th – 21st April 2023 It has been a great day of learning...
Read More
Executive Director’s Message
Greetings
Our mission is to improve the health status of families infected and affected by HIV/AIDS through research, training, prevention and care.
Announcements
Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis
30 March, 2023
Viral load non-suppression has been found to be associated with suboptimal ART adherence, and Intensive Adherence Counselling has been shown to lead to viral load re-suppression by over 70% in people living with HIV on ART. Dr. Catherine Nakaye explores this issue through a study carried out at Kiswa Health Centre in Kampala. Click here to read the article.
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial
April, 2023
Isoniazid preventive therapy (IPT) initiation during pregnancy was associated with increased incidence of adverse pregnancy outcomes in the TB APPRISE trial. Effects of in utero IPT exposure on infant growth are unknown. Co-author Dr. Deo Wabwire contributes to this analysis of data from the TB APPRISE (IMPAACT P1078) trial in eight countries with high tuberculosis prevalence. Click here to read the article.
Our Work
Our Partners
© 2022 MU-JHU Research Collaboration. All rights reserved